NCT05565872

Brief Summary

This project plans on a community-based exercise intervention (Urban Training) combined with therapeutic education program, by using public spaces and urban walkable trails, adapted to each patient needs and capabilities in patients with chronic obstructive pulmonary disease (COPD). The main objective of the present study is to evaluate the effects comparing different levels of supervision (face-to-face vs telematic) in the short-, medium- and long-term with respect to: (primary outcome): exercise capacity, and (secondary outcomes): physical activity, quality of life, mental health and COPD exacerbations.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable chronic-obstructive-pulmonary-disease

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 27, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 4, 2022

Completed
1 day until next milestone

Study Start

First participant enrolled

October 5, 2022

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 20, 2024

Completed
20 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 10, 2024

Completed
Last Updated

November 25, 2024

Status Verified

November 1, 2024

Enrollment Period

1.7 years

First QC Date

September 27, 2022

Last Update Submit

November 20, 2024

Conditions

Keywords

Exercise TherapyTelerehabilitationExercise TolerancePhysical Activity

Outcome Measures

Primary Outcomes (1)

  • Change in exercise capacity

    Change in exercise capacity between baseline, up to 13 weeks, 6 months and 12 months, as measured by 6-min walking distance

    Baseline, post-intervention (up to 13 weeks), 6 months and 12 months

Secondary Outcomes (4)

  • Change in physical activity

    Baseline, post-intervention (up to 13 weeks), 6 months and 12 months

  • Change in quality of life

    Baseline, post-intervention (up to 13 weeks), 6 months and 12 months

  • Change in anxiety and depression symptoms

    Baseline, post-intervention (up to 13 weeks), 6 months and 12 months

  • COPD exacerbations

    Post-intervention (up to 13 weeks), 6 months and 12 months

Other Outcomes (2)

  • The effect of an attendance at an urban training program on changes in self-efficacy

    Baseline, post-intervention (up to 13 weeks), 6 months and 12 months

  • Adherence to treatment

    Post-intervention (up to 13 weeks), 6 months and 12 months

Study Arms (2)

Urban training Intervention + therapeutic education program with face-to-face supervision

EXPERIMENTAL

Patients will be advised to walk in the defined urban trails with face-to-face supervision

Behavioral: Urban training

Urban training Intervention + therapeutic education program with telematic supervision

ACTIVE COMPARATOR

Patients will be advised to walk in the defined urban trails with telematic supervision

Behavioral: Urban training

Interventions

Urban trainingBEHAVIORAL

A community-based exercise intervention (Urban Training) by using public spaces and urban walkable trails, adapted to each patient needs and capabilities

Urban training Intervention + therapeutic education program with face-to-face supervisionUrban training Intervention + therapeutic education program with telematic supervision

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age \> 18 years
  • COPD diagnosed by pulmonary function tests during clinical stability, with a ratio of forced expiratory volume in one second (FEV1) to forced vital capacity (FVC) ≤ 0.70
  • Clinical stability, defined as at least 6 weeks without COPD exacerbation

You may not qualify if:

  • Neuromuscular or neurological disorders and/or psychiatric or cognitive conditions that hindered they ability to cooperate
  • Comorbidity that could interfere with study intervention (e.g., severe orthopaedic problems)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zona Básica de Salud Torrejón de Ardoz

Torrejón de Ardoz, Madrid, 28850, Spain

Location

Related Publications (2)

  • Arbillaga-Etxarri A, Gimeno-Santos E, Barberan-Garcia A, Balcells E, Benet M, Borrell E, Celorrio N, Delgado A, Jane C, Marin A, Martin-Cantera C, Monteagudo M, Montella N, Munoz L, Ortega P, Rodriguez DA, Rodriguez-Roisin R, Simonet P, Toran-Monserrat P, Torrent-Pallicer J, Vall-Casas P, Vilaro J, Garcia-Aymerich J. Long-term efficacy and effectiveness of a behavioural and community-based exercise intervention (Urban Training) to increase physical activity in patients with COPD: a randomised controlled trial. Eur Respir J. 2018 Oct 18;52(4):1800063. doi: 10.1183/13993003.00063-2018. Print 2018 Oct.

    PMID: 30166322BACKGROUND
  • Arbillaga-Etxarri A, Gimeno-Santos E, Barberan-Garcia A, Benet M, Borrell E, Dadvand P, Foraster M, Marin A, Monteagudo M, Rodriguez-Roisin R, Vall-Casas P, Vilaro J, Garcia-Aymerich J; Urban Training Study Group. Socio-environmental correlates of physical activity in patients with chronic obstructive pulmonary disease (COPD). Thorax. 2017 Sep;72(9):796-802. doi: 10.1136/thoraxjnl-2016-209209. Epub 2017 Mar 1.

    PMID: 28250201BACKGROUND

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveLung Diseases, ObstructiveRespiratory Tract DiseasesMotor Activity

Condition Hierarchy (Ancestors)

Lung DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBehavior

Study Officials

  • Tamara del Corral, PhD

    Universidad Complutense de Madrid

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 27, 2022

First Posted

October 4, 2022

Study Start

October 5, 2022

Primary Completion

June 20, 2024

Study Completion

July 10, 2024

Last Updated

November 25, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations